Significant Contract Modifications ($10M+) — April 08, 2026

Shionogi Inc secured a $119M cost-plus-fixed-fee contract (potential $482M base + options) from HHS BARDA for antibiotics targeting drug-resistant infections, with a 10-year period to 2036-03-10 under full competition.

Salient CRGT won a $93M time-and-materials delivery order (potential $199M) from VA Technology Acquisition Center for technical application platforms, with $22M already outlayed since April 2025 award.

Mantech Advanced Systems (parent Mantech International) received a $77M cost-plus-award-fee GSA delivery order for USSOUTHCOM cyber IT services, with ceiling up to $910M through potential 2032.

Vedanta Biosciences secured a $79M cost-sharing contract (potential $114M) from HHS BARDA, with $71M outlayed since 2020 for biotech R&D against antibiotic-resistant infections through 2027 (potential 2031).

IBM won a $90M firm-fixed-price delivery order (potential $148M) from Treasury IRS IT Operations for e-file IT services, with $51M outlayed since May 2024 through potential 2029.

IBM's $110M firm-fixed-price Treasury IRS e-file modernization order (fully outlayed) faces termination dated 3/24/2025 per executive orders, despite 2024 performance end.

Syncom Space Services (Amentum subsidiary) has $100M NASA obligation with $99M outlayed for Stennis Space Center operations through June 2025.

Zero outlays on top awards like Shionogi $119M HHS BARDA, Mantech $77M GSA, and Deloitte $70M State Dept expose delays in biotech/IT execution.

SmARTRONIX $116M GSA IT order shows negative -$162k outlayed on 2018-2023 contract, signaling potential de-obligation.

IBM $110M Treasury contract terminated 3/24/2025 per executive orders, risking final settlement on fully outlayed funds.

High fixed-price risks on Quality Support $113M State visa services (SDVOSB set-aside, $0 outlayed through 2026) and ENSCO $70M DOT rail inspection.

Mantech $77M GSA cyber IT order offers $910M ceiling via options for USSOUTHCOM through 2032.

Serco $96M PBGC engineering services delivery order with $239M potential through 2029.

Salient CRGT $93M VA IT platform services with $199M ceiling through potential 2030.

Shionogi and Vedanta HHS BARDA biotech R&D contracts ($119M + $79M obligations, up to $596M combined potential) for biothreat antibiotics.

Shionogi $119M and Vedanta $79M awards (combined $198M obligation, $596M potential) fund late-stage antibiotics development for drug-resistant pathogens through 2031-2036.

IT-heavy wins include Salient CRGT $93M VA, Mantech $77M GSA cyber, IBM $90M+$110M Treasury IRS, Deloitte $70M State (NAICS 541512 dominant).

VA awards to Salient CRGT $93M IT platforms, General Dynamics IT $65M computing, Greenbrier $61M software maintenance signal sustained IT/compute spending.

{"entity"=>"Shionogi Inc", "reason"=>"$119M HHS BARDA obligation at $0 outlayed; 10-year biotech R&D potential to $482M.", "trigger"=>"outlay progress, FDA milestones, 2036-03-10 options"}

{"entity"=>"Mantech International Corp", "reason"=>"$77M GSA USSOUTHCOM cyber IT with $910M ceiling, $0 outlayed.", "trigger"=>"option exercises post-2026-04-24"}

{"entity"=>"IBM Corporation", "reason"=>"Dual Treasury $200M+ IRS IT orders; one terminated 3/24/2025.", "trigger"=>"termination settlement, $148M options on active order"}

{"entity"=>"Salient CRGT Inc", "reason"=>"$93M VA IT order with $22M outlayed toward $199M potential.", "trigger"=>"outlay ramp, 2030-04-10 extension"}

{"entity"=>"Vedanta Biosciences Inc", "reason"=>"$79M HHS BARDA with $71M outlayed; options to $114M.", "trigger"=>"remaining drawdown, 2027-01-31 vs 2031-12-31 end"}